Mark Schneider, Nestlé CEO (Ludovic Marin/Pool via AP Images)
Nestlé parts with peanut allergy treatment Palforzia
Peanut allergies proved a tough nut to crack for Nestlé, which announced Monday it has divested its treatment Palforzia to Swiss …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
